```html

Xanthopsia from Jaundice

---

What is Xanthopsia from jaundice?

Xanthopsia is a visual disturbance in which objects appear yellow‑tinted. When it occurs in the setting of jaundice, the yellow hue is not an illusion created by the brain but a direct result of elevated bilirubin levels affecting the retina and optic pathways. Jaundice—characterized by yellowing of the skin and sclerae—signals that the liver is unable to process bilirubin efficiently. In severe hyperbilirubinemia, bilirubin can cross the blood‑retina barrier, altering the way photoreceptors respond to light and producing a pervasive yellow tint in the visual field.

Although relatively uncommon, xanthopsia can be an early clue that a patient’s bilirubin is rising to a level that may threaten the nervous system (bilirubin‑induced neurologic dysfunction), especially in infants (kernicterus) and in adults with acute liver failure. Recognizing this symptom early can prompt urgent evaluation and treatment, potentially preventing permanent visual or neurologic damage.

Common Causes

Below are the most frequent conditions that lead to jaundice‑related xanthopsia. Many of these disorders elevate bilirubin either by over‑production, impaired conjugation, or blocked excretion.

• Acute viral hepatitis (A, B, C, D, E) – Inflammation impairs hepatic uptake and conjugation of bilirubin.
• Alcoholic hepatitis – Alcohol damages hepatocytes and interferes with bilirubin processing.
• Drug‑induced liver injury – Acetaminophen overdose, amoxicillin‑clavulanate, certain antiretrovirals, and methotrexate are common culprits.
• Gallstone obstruction (choledocholithiasis) – Blocks bile flow, leading to conjugated hyperbilirubinemia.
• Primary sclerosing cholangitis (PSC) & primary biliary cholangitis (PBC) – Chronic cholestatic diseases cause bile duct scarring.
• Hemolytic anemias – Sickle cell disease, hereditary spherocytosis, or autoimmune hemolysis produce excess unconjugated bilirubin.
• Genetic disorders of bilirubin metabolism – Gilbert’s syndrome (mild) and Crigler‑Najjar syndrome (severe) affect conjugation.
• Neonatal physiologic jaundice – Immature liver enzymes; xanthopsia is rare but possible in severe cases.
• Liver cancer or metastatic disease – Tumor infiltration disrupts normal hepatic function.
• Sepsis with cholestasis – Critical illness can cause “cholestasis of sepsis,” raising bilirubin.

Associated Symptoms

Patients with xanthopsia caused by jaundice often notice a cluster of other signs that reflect the underlying liver dysfunction.

• Yellow discoloration of the skin, sclerae, and mucous membranes.
• Dark‑brown (tea‑colored) urine and pale or clay‑colored stools.
• Pruritus (intense itching), especially on the palms and soles.
• Upper abdominal pain or a sense of fullness in the right upper quadrant.
• Fatigue, malaise, and loss of appetite.
• Confusion, lethargy, or “hepatic encephalopathy” in severe cases.
• Fever and chills if infection (e.g., cholangitis) is present.
• Muscle cramps or abdominal tenderness from electrolyte disturbances.

When to See a Doctor

Because xanthopsia can signal dangerously high bilirubin levels, prompt medical evaluation is crucial. Seek care if you experience any of the following:

• Sudden onset of yellow‑tinged vision that does not resolve within a few hours.
• Visible yellowing of the skin or eyes, especially if it spreads rapidly.
• Severe itching that interferes with sleep or daily activities.
• Abdominal pain combined with fever or vomiting (possible cholangitis).
• Confusion, slurred speech, or difficulty concentrating.
• Persistent dark urine or pale stools lasting more than 24 hours.
• History of recent medication change, alcohol binge, or exposure to hepatitis risk factors.

In infants, any yellow tint to the skin or eyes after the first 24 hours of life, especially if accompanied by poor feeding or lethargy, requires immediate pediatric evaluation.

Diagnosis

1. Clinical Assessment

The clinician will begin with a thorough history (onset, medication use, alcohol intake, travel, family history) and a detailed physical exam focusing on the liver, gallbladder, and neurologic status.

2. Laboratory Tests

• Total and direct (conjugated) bilirubin – Helps differentiate hepatocellular vs. obstructive causes.
• Liver enzyme panel (ALT, AST, ALP, GGT) – Elevated transaminases suggest hepatocellular injury; high alkaline phosphatase points to cholestasis.
• Complete blood count (CBC) – Detects hemolysis or infection.
• Coagulation profile (PT/INR) – Liver synthetic function.
• Serologic tests – Hepatitis A‑E, HIV, autoimmune markers (ANA, ASMA) when indicated.
• Serum ammonia – Elevated in hepatic encephalopathy.

3. Imaging Studies

• Abdominal ultrasound – First‑line to evaluate gallstones, bile duct dilation, or liver texture.
• Magnetic resonance cholangiopancreatography (MRCP) – Detailed view of biliary tree if obstruction is suspected.
• CT scan or MRI – For tumor detection or trauma.

4. Ophthalmologic Evaluation

When visual changes are prominent, an eye specialist can perform:

• Fundoscopic exam – assesses retinal health; severe hyperbilirubinemia may cause “cherry‑red” spots.
• Color vision testing – quantitative confirmation of xanthopsia.
• Electroretinography (ERG) – detects functional impairment of photoreceptors.

5. Special Tests in Neonates

Transcutaneous bilirubin meters, total serum bilirubin (TSB) levels, and, if needed, brain MRI to rule out kernicterus.

Treatment Options

Addressing the Underlying Cause

• Viral hepatitis – Antiviral agents (e.g., sofosbuvir/velpatasvir for HCV) and supportive care.
• Alcoholic hepatitis – Abstinence, corticosteroids in select cases, and nutritional support.
• Drug‑induced injury – Immediate cessation of the offending drug; N‑acetylcysteine for acetaminophen toxicity.
• Biliary obstruction – Endoscopic retrograde cholangiopancreatography (ERCP) or surgical removal of stones/tumors.
• Autoimmune liver disease – Immunosuppressants such as prednisone or azathioprine.
• Hemolytic anemia – Transfusion, steroids, or disease‑specific therapy (e.g., hydroxyurea for sickle cell).

Rapid Reduction of Bilirubin

• Phototherapy – Wavelength‑specific light converts bilirubin into water‑soluble isomers; mainstay for neonates and occasionally adults with severe hyperbilirubinemia.
• Exchange transfusion – Replaces bilirubin‑laden blood; reserved for life‑threatening levels (>30 mg/dL in neonates or >25 mg/dL with neurologic symptoms in adults).
• Plasmapheresis – Removes circulating bilirubin and inflammatory mediators in acute liver failure.
• Liver‑support devices (MARS®, albumin dialysis) – Bridge to transplantation in select patients.

Symptomatic Relief

• **Pruritus control** – Cholestyramine, rifampin, or naltrexone.
• **Hydration** – Adequate fluid intake helps renal excretion of bilirubin.
• **Nutritional support** – High‑protein, low‑fat diet; supplement fat‑soluble vitamins (A, D, E, K) if malabsorption is present.

Home and Lifestyle Measures

• Avoid alcohol and hepatotoxic drugs.
• Maintain a healthy weight; obesity can worsen non‑alcoholic fatty liver disease (NAFLD).
• Stay up‑to‑date with vaccinations (HAV, HBV) to prevent viral hepatitis.
• Practice safe sex and use clean needles to reduce hepatitis transmission.

Prevention Tips

• Vaccinate against hepatitis A and B.
• Limit alcohol consumption – No more than 2 drinks/day for men, 1 for women.
• Use medications responsibly – Follow dosing guidelines for acetaminophen; ask providers about liver‑friendly alternatives.
• Maintain regular check‑ups if you have chronic liver disease or hemolytic disorders.
• Adopt a liver‑friendly diet – Plenty of fruits, vegetables, whole grains, and lean protein; limit saturated fats and sugars.
• Practice good hygiene – Hand washing and safe food preparation reduce viral hepatitis risk.
• Monitor newborn bilirubin – Follow pediatric guidance for phototherapy thresholds.

Emergency Warning Signs

Call 911 or go to the nearest emergency department if you experience any of the following:

• Sudden, severe yellowing of the eyes or skin with a bilirubin level > 20 mg/dL (adults) or > 25 mg/dL (infants).
• Rapid onset of confusion, seizures, or loss of consciousness – possible bilirubin‑induced neurologic dysfunction.
• High‑fever (> 101.5 °F / 38.6 °C) with right‑upper‑quadrant pain and jaundice (charcot’s triad – suggests acute cholangitis).
• Persistent vomiting, abdominal swelling, or inability to pass urine or stool.
• Intense, unrelenting itching accompanied by a rash or swelling of the face and neck.

---

Understanding that xanthopsia can be a visual manifestation of serious liver dysfunction empowers patients to seek timely care. Early recognition, appropriate laboratory work‑up, and targeted treatment of the underlying cause usually reverse the yellow‑tinted vision and prevent permanent complications.

References:

• Mayo Clinic. “Jaundice.” mayoclinic.org (accessed April 2026).
• National Institute of Diabetes and Digestive and Kidney Diseases. “Liver Disease and Bilirubin.” niddk.nih.gov.
• American Academy of Pediatrics. “Management of Hyperbilirubinemia in the Newborn.” Pediatrics, 2022.
• Cleveland Clinic. “Phototherapy for Jaundice.” clevelandclinic.org.
• World Health Organization. “Hepatitis Fact Sheets.” who.int.

```